5 Results for "

sAPPβ

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "sAPPβ" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-13240
CAS No.: 1262036-50-9
Purity:  99.72%
Target:  

Beta-secretase

Research Areas:  

Neurological Disease

LY2886721 is a potent, selective and orally active beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor with an IC50 of 20.3 nM for recombinant human BACE1. LY2886721 is selectivity against cathepsin D, pepsin, and renin, but lacking selectivity against BACE2 (IC50 of 10.2 nM). LY2886721 can across blood-brain barrier and has the potential for Alzheimer's disease treatment .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19918A
Anatabine dicitrate is a tobacco alkaloid that can cross the blood-brain barrier. Anatabine dicitrate is a potent α4β2 nAChR agonist. Anatabine dicitrate inhibits NF-κB activation lower amyloid-β (Aβ) production by preventing the β-cleavage of amyloid precursor protein (APP). Anatabine dicitrate has anti-inflammatory effects and has the potential for neurodegenerative disorders treatment .
loading...
    loading...
Cat. No.: HY-P1378A
Target:  

Amyloid-β

Research Areas:  

Neurological Disease

β-Amyloid (1-43)(human) TFA is more prone to aggregation and has higher toxic properties than the long-known Aβ1-42. β-Amyloid (1-43)(human) TFA shows a correlation with both sAPPα and sAPPβ. β-Amyloid (1-43)(human) TFA could be considered an added Alzheimer's disease (AD) biomarker together with the others already in use .
loading...
    loading...
Cat. No.: HY-P1378
CAS No.: 134500-80-4
Target:  

Amyloid-β

Research Areas:  

Neurological Disease

β-Amyloid (1-43)(human) is more prone to aggregation and has higher toxic properties than the long-known Aβ1-42. β-Amyloid (1-43)(human) shows a correlation with both sAPPα and sAPPβ. β-Amyloid (1-43)(human) could be considered an added Alzheimer's disease (AD) biomarker together with the others already in use .
loading...
    loading...
Cat. No.: HY-13240A
CAS No.: 1262036-49-6
Target:  

Beta-secretase

Research Areas:  

Neurological Disease

LY2886721 hydrochloride is a potent, selective and orally active beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor with an IC50 of 20.3 nM for recombinant human BACE1. LY2886721 hydrochloride is selectivity against cathepsin D, pepsin, and renin, but lacking selectivity against BACE2 (IC50 of 10.2 nM). LY2886721 hydrochloride can across blood-brain barrier and has the potential for Alzheimer's disease treatment .
loading...
    loading...